Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-FR | Version v2-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-04-10 | 2025-04-10 |
| Drug Identification Number | 02013886 | 02013886 |
| Brand name | CLINIMIX | CLINIMIX |
| Common or Proper name | 5% Amino Acids (Blend B) without Electrolytes in 5% Dextrose Injection | 5% Amino Acids (Blend B) without Electrolytes in 5% Dextrose Injection |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | L-ARGININE GLYCINE L-ALANINE METHIONINE L-LYSINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LEUCINE HYDROCHLORIDE DEXTROSE L-ISOLEUCINE L-TYROSINE L-PROLINE TRYPTOPHAN L-THREONINE HISTIDINE L-VALINE | L-ARGININE GLYCINE L-ALANINE METHIONINE L-LYSINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LEUCINE HYDROCHLORIDE DEXTROSE L-ISOLEUCINE L-TYROSINE L-PROLINE TRYPTOPHAN L-THREONINE HISTIDINE L-VALINE |
| Strength(s) | 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG | 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000 mL | 1000 mL |
| ATC code | B05BA | B05BA |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2025-07-31 | 2025-07-31 |
| Actual discontinuation date | ||
| Remaining supply date | 2025-07-31 | 2025-07-31 |
| Discontinuation status | To be discontinued | To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |